European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - modified live bovine viral diarrhoea virus type 1, non-cytopathic parent strain ke-9 and modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain ny-93 - immunologicals for bovidae, live viral vaccines - for active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (bvdv-1 and bvdv-2), and to reduce virus shedding and viraemia caused by bvdv-2.for active immunisation of cattle against bvdv-1 and bvdv-2, to prevent the birth of persistently infected calves caused by transplacental infection.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim vetmedica gmbh - bovine viral diarrhoea virus - lyophilisate and solvent for suspension for injection - live viral vaccine - cattle

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

boehringer ingelheim vetmedica inc., germany - modified live bvdv-1{bovine viral diarrhea virus type 1) non-cytopathic parent strain ke-9 and modified live bvdv-2 {bovine viral diarrhea virus type 2) noncytopathic parent stain ny-93 - solution for injection - 106 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

boehringer ingelheim vetmedica inc., germany - modified live bvdv-1{bovine viral diarrhea virus type 1) non-cytopathic parent strain ke-9 and modified live bvdv-2 {bovine viral diarrhea virus type 2) noncytopathic parent stain ny-93 - solution for injection - 106 iu